ArticleJournal of thoracic disease2020

A phase 2 study of adjuvant carboplatin plus S-1 followed by maintenance S-1 therapy for patients with completely resected stage II/IIIA non-small cell lung cancer-Japanese Northern East Area Thoracic Surgery Study Group JNETS1302 study.

Takeo Hasegawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.